10x Genomics Statistics
NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
76.10-4.56 (-5.65%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
10x Genomics by the numbers
10x Genomics has a market capitalization of $9.92 billion based on 120.21M shares outstanding. With trailing EPS of $-0.59, 10x Genomics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.4% above its 50-day average and 114.5% above its 200-day average.
Average daily trading volume is 3.15M shares, or about $239.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TXG valuation vs. peer median
| Metric | TXG | Peer median | Difference |
|---|---|---|---|
| Market cap | $9.92B | $5.51B | +80% |
| Avg. volume | 3.15M | 1.99M | +58% |
Peer median across 8 companies: AVTR, BIO, BRKR, RVTY, ALMR, PACB, CTKB, EYPT.
Valuation
- Market cap
- $9.92B
- Price / sales (latest FY)
- 15.42
- EPS (TTM)
- $-0.59
- Shares outstanding
- 120.21M
Price and trading
- Previous close
- 80.66
- Open
- 76.62
- Day range
- 73.00 – 82.72
- 52-week range
- 11.16 – 102.81
- 52-week change
- +556.03%
- Beta
- —
- Volume
- 9.37M
- Average volume
- 3.15M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 9.92B
- Forward Pe
- 992.57
- Eps
- -0.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 102.81
- Week52 Low
- 11.16
- Avg Volume
- 3.15M
- Shares Outstanding
- 120.21M
- Ma50
- 66.53
- Ma200
- 35.48
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -25.98%
- Pct From52w Low
- 581.90%